We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+7.63%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.77B
AUM Growth
+$83.3M
Cap. Flow
-$75.7M
Cap. Flow %
-1.59%
Top 10 Hldgs %
8.04%
Holding
1,297
New
101
Increased
425
Reduced
422
Closed
77

Top Buys

Rank Stock Value
1
PTEN icon
Patterson-UTI
PTEN
+$16M
2
CNXC icon
Concentrix
CNXC
+$14M
3
BUR icon
Burford Capital
BUR
+$12.4M
4
XPRO icon
Expro Ltd
XPRO
+$12.4M
5
PRGO icon
Perrigo
PRGO
+$11M

Sector Composition

Rank Sector Weight
1 Financials 28.75%
2 Consumer Discretionary 13.52%
3 Technology 11.88%
4 Industrials 10.57%
5 Energy 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WETH icon
1101
Wetouch Technology
WETH
$12.4M
$126K ﹤0.01%
+94,400
New +$183K
TGEN
1102
Tecogen Inc
TGEN
$118M
$126K ﹤0.01%
25,500
OMCC
1103
DELISTED
Old Market Capital Corp
OMCC
$125K ﹤0.01%
24,998
MVIS icon
1104
Microvision
MVIS
$77.1M
$125K ﹤0.01%
10,073
-6,667
-40% -$106K
AKA icon
1105
a.k.a. Brands
AKA
$119M
$123K ﹤0.01%
11,475
NTIC icon
1106
Northern Technologies International Corp
NTIC
$77.8M
$123K ﹤0.01%
15,661
PLCE icon
1107
Children's Place
PLCE
$60.3M
$120K ﹤0.01%
30,250
-10,000
-25% -$71.6K
GUTS icon
1108
Fractyl Health
GUTS
$111M
$120K ﹤0.01%
54,500
+9,000
+20% +$14.5K
PED icon
1109
PEDEVCO
PED
$142M
$119K ﹤0.01%
10,610
HYPR icon
1110
Hyperfine
HYPR
$96.1M
$117K ﹤0.01%
119,700
+40,000
+50% +$48.2K
QVCGA
1111
DELISTED
QVC Group Inc Series A
QVCGA
$116K ﹤0.01%
11,081
TCRX icon
1112
TScan Therapeutics
TCRX
$50.6M
$115K ﹤0.01%
115,400
-25,000
-18% -$36.2K
VATE icon
1113
INNOVATE Corp
VATE
$183M
$113K ﹤0.01%
25,000
CSTE icon
1114
Caesarstone
CSTE
$78.1M
$113K ﹤0.01%
60,601
-48,948
-45% -$68.8K
BRN icon
1115
Barnwell Industries
BRN
$14.1M
$111K ﹤0.01%
100,444
-70,230
-41% -$83.4K
MAPS
1116
DELISTED
WM TECHNOLOGY INC A
MAPS
$111K ﹤0.01%
134,700
-36,600
-21% -$36K
GEG icon
1117
Great Elm Group
GEG
$69M
$106K ﹤0.01%
41,545
KORE
1118
DELISTED
KORE Group Holdings
KORE
$104K ﹤0.01%
24,740
-20,000
-45% -$77.2K
ZNTL icon
1119
Zentalis Pharmaceuticals
ZNTL
$297M
$104K ﹤0.01%
77,300
GRWG icon
1120
GrowGeneration
GRWG
$90.7M
$104K ﹤0.01%
69,298
+50,801
+275% +$83.4K
OBIO icon
1121
Orchestra BioMed
OBIO
$252M
$104K ﹤0.01%
25,000
SCYX icon
1122
SCYNEXIS
SCYX
$53.5M
$104K ﹤0.01%
20,492
ACRV icon
1123
Acrivon Therapeutics
ACRV
$74M
$103K ﹤0.01%
42,900
+20,000
+87% +$43.5K
VRCA icon
1124
Verrica Pharmaceuticals
VRCA
$86.2M
$99.7K ﹤0.01%
12,000
MNOV icon
1125
MediciNova
MNOV
$66.4M
$99.6K ﹤0.01%
76,031

Similar funds

Bridgeway Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Bridgeway Capital Management held 1,297 positions worth $4.77B, up 1.8% from $4.69B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Bridgeway Capital Management's Q4 2025 filing shows 101 new, 425 increased, 422 reduced and 77 closed positions. Its largest new stake was Patterson-UTI: 2,679,554 shares worth $16.4M. The largest sale was Warrior Met Coal, an estimated $23M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bridgeway Capital Management's largest Q4 2025 buy was Patterson-UTI: 2,679,554 shares worth $16.4M.
  • Bridgeway Capital Management added most to Trustmark in Q4 2025, an estimated $9.24M increase.
  • Bridgeway Capital Management's biggest Q4 2025 reduction was Warrior Met Coal, cutting an estimated $23M.
  • Bridgeway Capital Management fully exited Premier in Q4 2025, selling an estimated $19.3M.
  • Bridgeway Capital Management's ten largest holdings make up 8% of its $4.77B portfolio in Q4 2025.
  • Bridgeway Capital Management opened 101 new positions and closed 77 in Q4 2025.
  • Bridgeway Capital Management's portfolio value rose 1.8% quarter-over-quarter to $4.77B.

Based on Bridgeway Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.